Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1963 1
1966 1
1971 1
1975 8
1976 11
1977 6
1978 4
1979 8
1980 2
1981 1
1982 9
1983 8
1984 15
1985 9
1986 15
1987 11
1988 5
1989 22
1990 23
1991 21
1992 23
1993 21
1994 20
1995 21
1996 23
1997 31
1998 30
1999 12
2000 28
2001 24
2002 24
2003 37
2004 27
2005 43
2006 30
2007 46
2008 39
2009 43
2010 45
2011 51
2012 58
2013 52
2014 66
2015 44
2016 45
2017 52
2018 66
2019 60
2020 71
2021 80
2022 86
2023 84
2024 67
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,498 results

Results by year

Filters applied: . Clear all
Page 1
Dermoscopic features of basal cell carcinoma and its subtypes: A systematic review.
Reiter O, Mimouni I, Dusza S, Halpern AC, Leshem YA, Marghoob AA. Reiter O, et al. J Am Acad Dermatol. 2021 Sep;85(3):653-664. doi: 10.1016/j.jaad.2019.11.008. Epub 2019 Nov 7. J Am Acad Dermatol. 2021. PMID: 31706938 Free PMC article.
BACKGROUND: Multiple studies have reported on dermoscopic structures in basal cell carcinoma (BCC) and its subtypes, with varying results. OBJECTIVE: To systematically review the prevalence of dermoscopic structures in BCC and its subtypes. ...Arborizing vess …
BACKGROUND: Multiple studies have reported on dermoscopic structures in basal cell carcinoma (BCC) and its subtypes, wi …
Diagnosis and Management of Basal Cell Carcinoma.
Tanese K. Tanese K. Curr Treat Options Oncol. 2019 Feb 11;20(2):13. doi: 10.1007/s11864-019-0610-0. Curr Treat Options Oncol. 2019. PMID: 30741348 Review.
Basal cell carcinomas (BCCs) are common skin cancers that tend to appear on sun-exposed skin. ...
Basal cell carcinomas (BCCs) are common skin cancers that tend to appear on sun-exposed skin. ...
Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT, Wu A, Figueira E, Huilgol S, Selva D. Sun MT, et al. Future Oncol. 2015 Nov;11(22):3003-10. doi: 10.2217/fon.15.190. Epub 2015 Oct 5. Future Oncol. 2015. PMID: 26437207 Review.
Basal cell carcinoma (BCC) is the most common eyelid malignancy; however, orbital invasion by periocular BCC is rare, and management remains challenging. ...
Basal cell carcinoma (BCC) is the most common eyelid malignancy; however, orbital invasion by periocular BCC is rare, a
Nonsurgical treatment options for basal cell carcinoma.
Rao H, Cartron A, Khachemoune A. Rao H, et al. JAAPA. 2022 Nov 1;35(11):38-43. doi: 10.1097/01.JAA.0000885180.48906.6d. JAAPA. 2022. PMID: 36282577
Basal cell carcinoma (BCC) is the most common form of nonmelanoma skin cancer. Surgery, including Mohs micrographic surgery, is considered the gold standard for the management of BCC, yet some patients may be unable to undergo surgery. This article describes
Basal cell carcinoma (BCC) is the most common form of nonmelanoma skin cancer. Surgery, including Mohs micrographic sur
Histologically Agressive Basal Cell Carcinoma With Particular Emphasis On Galeal Infiltration Of The Scalp.
Requena C, Serra-Guillén C, Sanmartín O. Requena C, et al. Actas Dermosifiliogr. 2022 Jun;113(6):575-582. doi: 10.1016/j.ad.2022.01.026. Epub 2022 Feb 12. Actas Dermosifiliogr. 2022. PMID: 35339267 Free article. Review. English, Spanish.
Familiarity with predictors of more aggressive behavior is crucial to the management of basal cell carcinoma (BCC). Risk factors for aggressive BCC are essentially divided into clinical and histopathologic factors. In this review we examine histopathologic fe …
Familiarity with predictors of more aggressive behavior is crucial to the management of basal cell carcinoma (BCC). Ris …
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.
Lipson EJ, Lilo MT, Ogurtsova A, Esandrio J, Xu H, Brothers P, Schollenberger M, Sharfman WH, Taube JM. Lipson EJ, et al. J Immunother Cancer. 2017 Mar 21;5:23. doi: 10.1186/s40425-017-0228-3. eCollection 2017. J Immunother Cancer. 2017. PMID: 28344809 Free PMC article. Clinical Trial.
Monoclonal antibodies that block immune regulatory proteins such as programmed death-1 (PD-1) have demonstrated remarkable efficacy in controlling the growth of multiple tumor types. Unresectable or metastatic basal cell carcinoma, however, has largely gone u …
Monoclonal antibodies that block immune regulatory proteins such as programmed death-1 (PD-1) have demonstrated remarkable efficacy in contr …
Basal cell carcinoma: clinical and pathological features.
Di Stefani A, Chimenti S. Di Stefani A, et al. G Ital Dermatol Venereol. 2015 Aug;150(4):385-91. Epub 2015 Jun 23. G Ital Dermatol Venereol. 2015. PMID: 26099353
Basal cell carcinoma (BCC) is a slow-growing, locally invasive malignant epidermal skin neoplasm that represents the most common malignancy in Caucasians. ...From a histopathological point of view various subtypes has been described: nodular, superficial,
Basal cell carcinoma (BCC) is a slow-growing, locally invasive malignant epidermal skin neoplasm that represents the mo
Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy.
Kuijpers DI, Thissen MR, Neumann MH. Kuijpers DI, et al. Am J Clin Dermatol. 2002;3(4):247-59. doi: 10.2165/00128071-200203040-00003. Am J Clin Dermatol. 2002. PMID: 12010070 Review.
The incidence of basal cell carcinoma is rapidly increasing and a number of treatment modalities are available. ...Special attention is needed when treating the more aggressive subtypes of the disease, such as the micronodular, infiltrative, adenoid an …
The incidence of basal cell carcinoma is rapidly increasing and a number of treatment modalities are available. ...Spec …
Basal cell carcinoma: Epidemiological impact of clinical versus histopathological diagnosis.
Backman E, Oxelblom M, Gillstedt M, Dahlén Gyllencreutz J, Paoli J. Backman E, et al. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):521-527. doi: 10.1111/jdv.18774. Epub 2022 Dec 7. J Eur Acad Dermatol Venereol. 2023. PMID: 36433707
BACKGROUND: Low-risk basal cell carcinomas (BCCs) are to an increasing extent diagnosed by dermatologists through dermoscopic examination only and treated with non-surgical methods. ...The reports from the two pathology laboratories showed that histopathologically v …
BACKGROUND: Low-risk basal cell carcinomas (BCCs) are to an increasing extent diagnosed by dermatologists through dermoscopic …
Comparison of Sonographic Characteristics Between Superficial Basal Cell Carcinoma and Non-Superficial Basal Cell Carcinomas.
Liang JF, Luo PP, Zhang Y, Zhao G, Zhou M, Wang J. Liang JF, et al. J Ultrasound Med. 2023 Jul;42(7):1549-1556. doi: 10.1002/jum.16174. Epub 2023 Jan 13. J Ultrasound Med. 2023. PMID: 36637366
OBJECTIVES: To compare the sonographic characteristics of superficial basal cell carcinoma (sBCC) and non-superficial basal cell carcinomas (nsBCC). METHODS: The ultrasound characteristics of 73 basal cell carcinoma (BCC) co …
OBJECTIVES: To compare the sonographic characteristics of superficial basal cell carcinoma (sBCC) and non-superficial …
1,498 results